International conference on pharmaceutical pricing and reimbursement policies

12 - 13 October 2015, Vienna, Austria

Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis

The third International PPRI (Pharmaceutical Pricing and Reimbursement Policies) Conference aims to present latest academic analysis and foster discussion of challenges in pricing and reimbursement policies. Its objective is to encourage a dialogue among all stakeholders in the pharmaceutical field on the subject.
Focusing on the challenges beyond the financial crisis, the conference will bring together around 300 high-level academics, stakeholders and policy-makers to discuss current challenges and opportunities in the area of pharmaceutical policies.

The conference is being organized by the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies at the Department of Health Economics at the Austrian Health Institute (Gesundheit Österreich GmbH) in Vienna. The WHO Collaborating Centre was established in summer 2010 and redesignated as a centre of expertise in summer 2014.

A critical look at pharmaceutical pricing and reimbursement policies

A variety of pricing and reimbursement policies are used in different health care systems to ensure access to essential medicines for all patients. These policies aim at allocating the available resources in an equitable and efficient manner, balancing the often conflicting needs of access to medicines and containing costs. 

The recent financial crisis has put an extra burden on already strained resources in healthcare systems, which has led to many policy reforms and initiatives for efficient and rational use of medicines. Current developments, for instance in new high-cost medicines, bring further challenges and pressure for change. They, however, also constitute large opportunities for health care systems

The conference aims to bring together thought leaders from around the globe to discuss priority issues in pricing and reimbursement policies of pharmaceuticals – both from a global as well as European perspective. Current challenges and opportunities will be discussed, in particular also policy coordination and interface management issues. The impacts and lessons learned from policies implemented in response to the financial crisis will also be debated.

Registrations for the Conference are open till  30 September.

A young researcher award will be given to the best abstract submission by a researcher below the age of 35.

For further information on the Conference please visit the conference website.